Innovative Research and Newest Treatments
Donate to Support Cancer Research
Support from our donors advances the mission of the Lifespan Cancer Institute, helping our team provide expert patient care and conduct leading-edge research.
The Lifespan Cancer Institute at Rhode Island, The Miriam, and Newport hospitals is an active clinical trials site, committed to providing patients with the latest protocols. Our patients have access to groundbreaking new immunotherapies and other new and emerging cancer treatments at various stages of diagnosis and across many cancer types. Our medical professionals can answer questions and help determine whether participation in one of our research programs is beneficial for the patient.
Cancer treatments include the latest chemotherapy, biologic agents, radiation oncology, surgery, and image-guided procedures. Many of these are not available elsewhere in New England.
Lifespan and Dana-Farber Cancer Institute
The Dana-Farber Cancer Institute and the Lifespan Cancer Institute have created a strategic alliance to advance cancer treatment and research. Learn more »
COBRE Center for Cancer Research Development
In addition, the COBRE Center for Cancer Research Development (CCRD) is the only hospital-based center for cancer research in Rhode Island that is funded by the National Institutes of Health. Science research conducted at this center is used to design and implement novel diagnostic and treatment protocols benefiting patients at the Lifespan Cancer Institute and in the community at large. Learn more »
Brown University Oncology Group
Our Lifespan Cancer Institute physicians also actively participate in the Brown University Oncology Group (BrUOG), a unique regional clinical trials network that provides highly innovative approaches to cancer care. Learn more »
The Joint Program in Cancer Biology
The Joint Program in Cancer Biology at Brown and Lifespan is a world-class cancer research program brings basic science discoveries about cancer, interdisciplinary clinical, translational, and population research to innovative therapeutic, disease intervention and cancer prevention clinical trials to patients in Rhode Island. Learn more »